Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Aktas, US
Ayten Celik Aktas, Urbana, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20090297422 | Machining nanometer-sized tips from multi-walled nanotubes - The invention provides sharpened multi-walled nanotubes and methods for sharpening multi-walled nanotubes. The methods of the invention use an electron beam to machine the multi-walled nanotube to the desired dimensions. The invention provides sharpened boron nitride nanotubes where the radius of the end of the sharpened tip is less than about 10 nm. | 12-03-2009 |
Bertal Huseyin Aktas, Newton, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20120077759 | 3-3-Di-Substituted-Oxindoles as Inhibitors of Translation Initiation - Compositions and methods for inhibiting translation using 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and/or its derivatives are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2) non-proliferative, degenerative disorders, (3) viral infections, and/or (4) disorders associated with viral infections, using 3-(5-tert-butyl-2-hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and/or its derivatives are described. | 03-29-2012 |
Birol Aktas, Wilmington, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20090296875 | FUEL SUPPORTS FOR NUCLEAR REACTORS - A fuel support for a nuclear reactor may include: a plurality of fuel support apertures, each fuel support aperture dimensioned for receiving a lower tie plate of a fuel assembly; and a plurality of lumens, each lumen being coupled to a different fuel support aperture. At least one lumen may be configured for attenuating a fluid flow differently than the fluid flow in at least one other of the lumen. | 12-03-2009 |
| 20100220829 | CONTROL ROD GUIDE TUBE AND METHOD FOR PROVIDING COOLANT TO A NUCLEAR REACTOR FUEL ASSEMBLY - Control rod guide tubes for a nuclear reactor having a body with an axial length that defines a lower end portion and an upper end portion and a cavity within a substantial length of the body. Orifices are included at the upper and lower end portions of the body. A control rod chamber is located within the cavity and is configured for receiving a control rod. A plurality of ports is coupled to the cavity and is positioned at a substantial length from the upper end portion of the body. Also included are at least two flow channels within the cavity that extend a substantial portion of the axial length of the body. Each flow channel is fluidly coupled to one or more of the ports for receiving fluid flow from outside the body and an outlet proximate to the upper end portion of the body for providing the received fluid flow. | 09-02-2010 |
| 20110080988 | FUEL BUNDLE DESIGNS USING MIXED SPACER TYPES - Example embodiment fuel bundles use multiple types of spacers within the same fuel bundle. The type for each spacer location may be determined based on the axial position of the spacer, the characteristics of the spacer type, and the location and coolant characteristics for the particular example fuel bundle including the spacers. Historic performance data for the particular bundle location, predictive modeling, etc. may be used to determine what spacer types at which locations result in the best operating conditions and margins for example fuel bundles. | 04-07-2011 |
Huseyin Aktas, Newton, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090299058 | 3-3-DI-SUBSTITUTED-OXINDOLES AS INHIBITORS OF TRANSLATION INITIATION - Compositions and methods for inhibiting translation using 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and/or its derivatives are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2) non-proliferative, degenerative disorders, (3) viral infections, and/or (4) disorders associated with viral infections, using 3-(5-tert-butyl-2-hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and/or its derivatives are described. | 12-03-2009 |
| 20100144805 | Regulation of protein synthesis - A composition and method for inhibiting proliferation of a tumor cell compared to a non-tumor cell. Also described are methods of screening for a composition that inhibits cap-dependent translation compared to cap-independent translation of proteins. | 06-10-2010 |
| 20100249201 | 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation - Compositions and methods for inhibiting translation using 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and/or its derivatives are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2) non-proliferative, degenerative disorders, (3) viral infections, and/or (4) disorders associated with viral infections, using 3-(5-tert-butyl-2-hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and/or its derivatives are described. | 09-30-2010 |
| 20110046367 | 3-3-DI-SUBSTITUTED-OXINDOLES AS INHIBITORS OF TRANSLATION INITIATION - Compositions and methods for inhibiting translation using 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and/or its derivatives are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2) non-proliferative, degenerative disorders, (3) viral infections, and/or (4) disorders associated with viral infections, using 3-(5-tert-butyl-2-hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and/or its derivatives are described. | 02-24-2011 |